Aller au contenu
Santé cardiovasculaireArticle de recherche3 min read

Higher blood inflammation index (SIRI) linked to higher death risk in hypertension

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension. · Frontiers in cardiovascular medicine · 2023 · Article original ↗

À retenir

Among 21,506 US adults with hypertension, a higher systemic inflammatory response index (SIRI) was associated with higher all-cause mortality (HR 1.19, CI 1.15-1.22) and cardiovascular mortality (HR 1.19, CI 1.15-1.24). The link is observational and rests on a single blood-count measurement, so it cannot show that lowering SIRI would prevent deaths.

Study design

Article de recherche

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Inflammation plays a part in how hypertension develops, and SIRI, a blood-count index, has been tied to mortality in other settings. It was unclear whether SIRI relates to death in people who already have hypertension, and the authors set out to test that.

Population et méthode

Cohort analysis of 21,506 participants with hypertension in the National Health and Nutrition Examination Survey (NHANES), 1999 to 2018, followed for survival through 31 December 2019. SIRI was calculated as neutrophil count multiplied by monocyte count divided by lymphocyte count. Hypertension was defined by blood pressure examination, prescription, or self-reported physician diagnosis. The authors used restricted cubic splines for non-linearity, Kaplan-Meier curves, weighted Cox regression adjusted for covariates, and receiver operating curves for predictive ability.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    During 189,063 person-years of follow-up, 5,680 participants (26.41%) died, including 1,967 (9.15%) from cardiovascular causes.
  2. 2
    After adjustment, higher SIRI was associated with higher all-cause mortality, HR 1.19 (1.15, 1.22), and cardiovascular mortality, HR 1.19 (1.15, 1.24).
  3. 3
    The relationship with both all-cause and cardiovascular mortality was J-shaped, and Kaplan-Meier curves showed higher mortality in higher SIRI quartiles than in lower ones.
  4. 4
    The authors report the result held in subgroup and sensitivity analyses.

Limites et incertitude

  1. 1
    SIRI was based on blood counts at one point in time, and any acute illness or infection at that moment could raise it and also relate to dying.
  2. 2
    The abstract does not state the unit for the hazard ratio (per unit, per SD or per quartile) or which covariates were adjusted for, so the size of the effect is hard to interpret.
  3. 3
    The J-shaped pattern means the link is not a simple straight line: risk was not lowest at the lowest SIRI values.
  4. 4
    The cohort is a US national survey with hypertension defined partly by self-report. The authors themselves call for larger cohort studies to confirm. This reading is based on the abstract only.

Mise en perspective

A blood-count inflammation marker may add information about long-term risk in people with hypertension, but this study does not show it should change treatment or that lowering it helps. SIRI comes from a standard blood test, so ask your clinician if you want to know what your own results mean. Keep taking prescribed blood pressure medication as directed.

Vos données

SIRI is not something a wearable measures; it needs a lab blood count (neutrophils, monocytes, lymphocytes). What you can track at home is blood pressure with a validated cuff, taken at the same time and posture, and your trend over weeks rather than single readings.

Comprendre ce type de preuve

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Inflammation plays an essential role in the pathogenesis of hypertension. A novel inflammatory biomarker systemic inflammatory response index (SIRI) is related with all-cause and cardiovascular (CVD) mortality, while the role of SIRI in hypertension patients is unclear.

Methods

A total of 21,506 participants with hypertension were recruited in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. SIRI was calculated as the neutrophil count ^(*) monocyte count/lymphocyte count. Hypertension was defined according to the examination of blood pressure, prescription, and self-reported physician diagnosis. Survival status was followed through 31 December 2019. The non-linear relationship was assessed using restricted cubic spline analysis. The association of all-cause mortality with SIRI was evaluated using the Kaplan-Meier curve and the weighted Cox regression analysis. The predictive abilities were assessed with Receiver operating curve.

Results

During 189,063 person-years of follow-up, 5,680 (26.41%) death events were documented, including 1,967 (9.15%) CVD related deaths. A J-shaped association was observed between SIRI and all-cause and CVD mortality. The Kaplan-Meier curve indicated the all-cause and CVD mortality risks were higher in high SIRI quartiles compared with lower SIRI quartiles. After adjusting for all covariates, the SIRI was positively associated with the all-mortality risk with HR = 1.19 (1.15, 1.22), and CVD mortality with HR = 1.19 (1.15, 1.24). The result was robust in subgroup analysis and sensitivity analysis.

Conclusion

Elevated SIRI level is associated with increased all-cause and CVD mortality among patients with hypertension. SIRI is considered as a potential inflammatory biomarker in the clinical practice. Further large-scale cohort studies are required to confirm our findings.

Sources et attribution

Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension.

Zhao S, Dong S, Qin Y, Wang Y, Zhang B, Liu A.

Frontiers in cardiovascular medicine · 2023-01-11

DOI: 10.3389/fcvm.2022.1066219 ↗PubMed · 36712259 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Santé cardiovasculaire →